Society of Nuclear Medicine and Molecular Imaging (SNMMI)

New in Uptake: SNMMI Launches Task Force to Drive Adoption of Emerging Nuclear Medicine Technologies A new SNMMI-TS Emerging Technologies and Radiopharmaceuticals Task Force has replaced the PET/MRI Task Force. The primary mission of the new task force is to identify emerging technologies, assess their intersection with nuclear medicine, and engage and educate technologists to promote wider adoption. Learn more below: https://lnkd.in/euzRhJJt

Technegas is an imaging agent that was approved by the U.S. FDA in September of 2023. The March 2025 issue of JNMT has published a helpful guide for implementing this new agent into clinical practice. We’ve done a brief overview of the highlights here. For more in-depth information, read the full article in JNMT: https://lnkd.in/eZzUjGvT

Meet Mary Beth Farrell, CNMT! In our first video, she shares how her work in continuing education is helping to accelerate the cure. Want to learn more about CE? Join us at the 2025 SNMMI Annual Meeting this June in New Orleans! Watch now and be part of the future of nuclear medicine. #SNMMI2025 #AcceleratingTheCure

Executive function is a key part of our everyday lives, and understanding how it works is critical to diagnosing and treating common neurological and psychiatric disorders like depression, anxiety, ADHD, and more. For the first time, the chemical dopamine has been directly linked to executive function through PET imaging. Learn more in this study published in this month’s JNM: https://lnkd.in/edFc86M4

??Conference catch-up! Dr. Shilpa Surasi gave a talk on "PSMA-Based Therapy in Advanced Disease: Touching on Combination Sequencing at last month's American Society of Clinical Oncology (ASCO) GU Symposium. Her talk was a result of the Prostate Cancer Outreach Working Group's proposal, and she spoke to a packed house!

Will tariffs on Mexico impact the nuclear medicine industry? Experts say yes. A recent article published by Radiology Business outlines the impact of a proposed 25% tariff on Mexico, our biggest trading partner in the medical manufacturing industry. We’re highlighting some of the most important info here. Learn more below, and stay tuned for a follow-up piece on the effect of tariffs on radiopharmaceuticals.

Triple-negative breast cancer (TNBC) is an especially deadly subtype of breast cancer that’s difficult to diagnose and treat. But we may have more insight now than ever thanks to a new radiotracer that can visualize Nectin-4, a biomarker found in TNBC. Learn more about the radiotracer that identified TNBC tumors with more precision than ever. The full article can be found in this month’s issue of JNM: https://lnkd.in/e3DbJGs6

Today is International Women's Day, and SNMMI celebrates all of the trailblazing women in the nuclear medicine field whose expertise, passion, and dedication contribute to the highest standards of patient care. We asked women leaders in SNMMI to reflect on their experiences as women in the nuclear medicine field, and here's what they said:

Do you love a good detective story? Us too! But lately, it seems like most things we read on the internet need their own independent investigation. In healthcare, it's more important than ever that the information we learn, train with, and pass on to patients is both accurate and helpful. So for episode 2 of the JNMT podcast, we're turning to expert Jennifer Prekeges, who teaches critical thinking at Bellevue College. Join host Jessica Settle for the ultimate healthcare detective story. Watch the full episode here or wherever you stream podcasts: https://lnkd.in/gCxy4pKi

The first issue of JNMT in 2025 is now published! Check out a few highlights: >Continuing education: Delivery Methods of Radiopharmaceuticals: Exploring Global Strategies to Minimize Occupational Radiation Exposure >Practical Protocols: Ventilation Lung Imaging: Technegas >Editors' Forum: Generative Artificial Intelligence in Nuclear Medicine Education >Teaching Case Studies: [18F]FDG PET/CT in Metastatic Extragonadal Choriocarcinoma >...and more! Read the full issue here:?https://lnkd.in/dhY7jPhC